KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Colgate Palmolive (CL) Change in Inventory (2016 - 2025)

Historic Change in Inventory for Colgate Palmolive (CL) over the last 17 years, with Q3 2025 value amounting to -$6.0 million.

  • Colgate Palmolive's Change in Inventory fell 10779.22% to -$6.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.0 million, marking a year-over-year decrease of 10600.0%. This contributed to the annual value of $100.0 million for FY2024, which is 15154.64% up from last year.
  • Per Colgate Palmolive's latest filing, its Change in Inventory stood at -$6.0 million for Q3 2025, which was down 10779.22% from -$89.0 million recorded in Q2 2025.
  • In the past 5 years, Colgate Palmolive's Change in Inventory ranged from a high of $215.0 million in Q1 2022 and a low of -$96.0 million during Q3 2023
  • In the last 5 years, Colgate Palmolive's Change in Inventory had a median value of $6.0 million in 2024 and averaged $15.9 million.
  • As far as peak fluctuations go, Colgate Palmolive's Change in Inventory skyrocketed by 1180000.0% in 2022, and later crashed by 41785.71% in 2025.
  • Colgate Palmolive's Change in Inventory (Quarter) stood at $35.0 million in 2021, then tumbled by 354.29% to -$89.0 million in 2022, then surged by 50.56% to -$44.0 million in 2023, then surged by 113.64% to $6.0 million in 2024, then crashed by 200.0% to -$6.0 million in 2025.
  • Its Change in Inventory stands at -$6.0 million for Q3 2025, versus -$89.0 million for Q2 2025 and $86.0 million for Q1 2025.